China Tian Yuan Healthcare Group Limited (HK:0557)
:0557
Want to see HK:0557 full AI Analyst Report?
Top Page
China Tian Yuan Healthcare Group Limited
(0557)
Select Model
Select Model
Rating:45Neutral
Price Target:
HK$0.44
▼(-36.57% Downside)
Action:Reiterated
Date:05/08/26
The score is held down primarily by deteriorating revenues and persistent operating/net losses despite decent gross margins. Technicals also remain weak with price trading below key moving averages and negative MACD. Manageable leverage and recently positive free cash flow provide some support but are not enough to offset the earnings and trend risks.
Positive Factors
Manageable leverage
A debt-to-equity ratio near 0.20–0.24 signals a conservative capital structure that reduces refinancing and interest-rate risk. Over the next several months this financial flexibility supports operations while the company addresses profitability issues and enables targeted investment or restructuring without immediate solvency pressure.
Negative Factors
Revenue contraction
A ~27% revenue decline in 2025 and levels materially below 2021 indicate durable top-line weakness. Persistent contraction erodes scale, reduces pricing/negotiating leverage, and worsens fixed-cost absorption, making margin recovery harder and constraining investment in customer retention or product development over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Manageable leverage
A debt-to-equity ratio near 0.20–0.24 signals a conservative capital structure that reduces refinancing and interest-rate risk. Over the next several months this financial flexibility supports operations while the company addresses profitability issues and enables targeted investment or restructuring without immediate solvency pressure.
Read all positive factors
China Tian Yuan Healthcare Group Limited (0557) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$183.53M
Dividend YieldN/A
Average Volume (3M)3.33K
Price to Earnings (P/E)―
Beta (1Y)-0.69
Revenue Growth-28.56%
EPS Growth0.58%
CountryHK
Employees34
SectorHealthcare
Sector Strength45
IndustryTravel Lodging
Share Statistics
EPS (TTM)-0.08
Shares Outstanding398,979,520
10 Day Avg. Volume1,000
30 Day Avg. Volume3,326
Financial Highlights & Ratios
PEG Ratio14.09
Price to Book (P/B)1.73
Price to Sales (P/S)14.56
P/FCF Ratio30.63
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
China Tian Yuan Healthcare Group Limited Business Overview & Revenue Model
Company Description
China Tian Yuan Healthcare Group Limited, an investment holding company, provides healthcare related services in Hong Kong, Korea, and the People's Republic of China. It operates through Investment Holding, Healthcare, Money Lending and Related Bu...
China Tian Yuan Healthcare Group Limited Financial Statement Overview
Summary
Income Statement
24
Negative
Balance Sheet
58
Neutral
Cash Flow
55
Neutral
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 19.18M | 26.84M | 45.23M | 54.22M | 94.59M |
| Gross Profit | 9.59M | 14.91M | 24.98M | 34.83M | 71.31M |
| EBITDA | -3.51M | -27.22M | -15.79M | -13.08M | -2.89M |
| Net Income | -34.01M | -34.24M | -15.48M | -29.04M | -16.85M |
Balance Sheet | |||||
| Total Assets | 224.98M | 260.93M | 302.95M | 333.55M | 376.40M |
| Cash, Cash Equivalents and Short-Term Investments | 29.51M | 27.05M | 26.73M | 31.60M | 77.89M |
| Total Debt | 38.72M | 45.97M | 45.91M | 51.13M | 59.66M |
| Total Liabilities | 88.36M | 84.98M | 87.77M | 91.52M | 92.35M |
| Stockholders Equity | 161.22M | 194.68M | 230.26M | 224.30M | 256.25M |
Cash Flow | |||||
| Free Cash Flow | 9.12M | 10.67M | 4.51M | -31.71M | 14.86M |
| Operating Cash Flow | 9.41M | 10.69M | 5.10M | -30.36M | 16.32M |
| Investing Cash Flow | -292.00K | -3.00K | 364.00K | -1.23M | -1.42M |
| Financing Cash Flow | -5.05M | -10.85M | -8.77M | -12.49M | -7.22M |
China Tian Yuan Healthcare Group Limited Technical Analysis
Negative
0.70
Price Trends
0.49
Negative
0.60
Negative
0.72
Negative
Market Momentum
-0.02
Negative
45.70
Neutral
62.88
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0557, the sentiment is Negative. The current price of 0.7 is above the 20-day moving average (MA) of 0.47, above the 50-day MA of 0.49, and below the 200-day MA of 0.72, indicating a bearish trend. The MACD of -0.02 indicates Negative momentum. The RSI at 45.70 is Neutral, neither overbought nor oversold. The STOCH value of 62.88 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0557.
China Tian Yuan Healthcare Group Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
60 Neutral | HK$368.36M | -1.88 | -2.56% | ― | 4.68% | 38.70% | |
53 Neutral | HK$222.66M | -0.34 | -18.68% | ― | 40.19% | 27.17% | |
52 Neutral | HK$476.35M | -0.24 | -29.62% | ― | 51.08% | 55.72% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | HK$234.06M | -0.21 | -13.53% | ― | 38.87% | 28.18% | |
45 Neutral | HK$183.53M | -8.21 | -33.69% | ― | -28.56% | 0.58% | |
41 Neutral | HK$1.69B | -0.41 | -20.38% | ― | 798.63% | 56.55% |
* Healthcare Sector Average
HK:0557
China Tian Yuan Healthcare Group Limited
0.46
-0.34
-42.50%
HK:0219
Shun Ho Property Investments Ltd
0.72
0.20
38.46%
HK:0355
Century City International Holdings Limited
0.07
0.03
94.59%
HK:0617
Paliburg Holdings Limited
0.21
-0.11
-35.63%
HK:0078
Regal Hotels International Holdings Limited
0.53
0.07
15.22%
HK:0199
ITC Properties Group Limited
1.41
1.21
605.00%
China Tian Yuan Healthcare Group Limited Corporate Events
China Tian Yuan Healthcare Unit Signs 2026 Connected Services Deal With Parent
Apr 20, 2026
China Tian Yuan Healthcare Group’s indirect non-wholly owned subsidiary Deshang Clinic has entered into a 2026 Service Framework Agreement with ultimate holding company Ningxia Tianyuan, under which it will provide occupational health examin...
China Tian Yuan Healthcare Posts Another Annual Loss on Lower Revenue and Goodwill Impairment
Mar 30, 2026
China Tian Yuan Healthcare Group Limited, a Hong Kong-listed healthcare group incorporated in the Cayman Islands, reported audited consolidated results for the year ended 31 December 2025. The company’s activities span healthcare operations ...
China Tian Yuan Healthcare Schedules Board Meeting to Approve 2025 Results and Consider Dividend
Mar 10, 2026
China Tian Yuan Healthcare Group Limited has scheduled a board meeting for 30 March 2026 in Hong Kong to review and approve the audited annual results for the year ended 31 December 2025. The board will also consider the declaration of a final div...
China Tian Yuan Healthcare Completes Acquisition of 70% Stake in Target Company
Mar 3, 2026
China Tian Yuan Healthcare Group Limited has completed the acquisition of a 70% equity interest in a target company for a consideration of RMB2.1 million, with completion taking place on 3 March 2026. The closing of this discloseable transaction m...
China Tian Yuan Healthcare Names Veteran Accountant as New Company Secretary
Feb 27, 2026
China Tian Yuan Healthcare Group Limited has announced a change in its company secretary, appointing Ms. Lai Pik Chi Peggy with effect from 27 February 2026, following the resignation of Mr. Siu Man On on the same date. The board noted that Mr. Si...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.